Novavax Reports Fourth Quarter and Year-End 2018 Financial Results

Go back to Novavax Reports Fourth Quarter and Year-End 2018 Financial Results

Novavax (NVAX) Misses Q4 EPS by 1c

March 18, 2019 4:10 PM EDT

Novavax (NASDAQ: NVAX) reported Q4 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $6.1 million versus the consensus estimate of $7.09 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

... More